Linked Data API

Show Search Form

Search Results

1717008
registered interest false remove filter
date less than 2024-05-09more like thismore than 2024-05-09
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Cambridge University Hospitals NHS Foundation Trust: Transgender People more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the guidance issued by Cambridge University Hospitals which states that: "Staff will be used as chaperones according to the gender they identify ... [and] will not share their trans status with patients nor would it be appropriate for any colleague either to share the trans status or another colleague with a patient or visitor”; and what assessment they have made of the compatibility of this guidance with the Government's definition of sex as biological sex in the context of intimate care. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL4508 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-21more like thismore than 2024-05-21
answer text <p>Cambridge University Hospital does not recognise the wording provided in the question as belonging to their chaperone’s guidance. The Government has been clear about the importance of biological sex, and the importance of respecting the privacy, dignity, and safety of all patients.</p><p>Our proposed changes to the NHS Constitution reinforce the National Health Services’ commitment to providing single-sex wards, and will empower patients to request that intimate care is carried out by someone of the same biological sex, where this is reasonably possible.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-05-21T12:26:06.707Zmore like thismore than 2024-05-21T12:26:06.707Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1700684
registered interest false remove filter
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Health Services: Women more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether it is their policy for the NHS to refer to "people who have ovaries" rather than "women" and whether this phraseology has been market tested with women, including those for whom English is a second language, to ensure that it is fully understood. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL3742 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-26more like thismore than 2024-04-26
answer text <p>It is not Government policy for the National Health Service to refer to ‘people who have ovaries’ and this phraseology has not been market tested. We have been clear that biological sex matters and it is important to use language that recognises the separate health and biological needs of men and women.</p><p>For all sex-specific conditions, we expect the language used to put biological sex, for example “women”, front and centre, with biologically-relevant information relating to specific organs or hormones secondary.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-26T11:09:53.75Zmore like thismore than 2024-04-26T11:09:53.75Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1699223
registered interest false remove filter
date less than 2024-03-26more like thismore than 2024-03-26
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Gender Plus more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether they have reviewed the decision of the Care Quality Commission to approve the registration of Gender Plus Healthcare in east London, which runs the private Gender Plus hormone clinic set up by former Tavistock Gender Identity Development Service specialist Dr Aidan Kelly, and which can refer patients aged 16 to 18 for cross-sex hormone treatment. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL3613 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-11more like thismore than 2024-04-11
answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and social care in England, and one of its statutory responsibilities is to assess and register providers of regulated activity, as set out in schedule one of the Health and Social Care Act 2008. Gender Plus Healthcare is a United Kingdom based private gender clinic offering a range of treatment options, including hormone treatment, for those aged 16 years old and over.</p><p>In January 2024 the CQC approved Gender Plus Healthcare’s registration to carry out the regulated activity of treatment of disease, disorder, or injury, with the provider having met the CQC’s requirements for registration. The registration by the CQC was on the condition that the provider must not carry out the regulated activity of treatment of disease, disorder, or injury, on those under the age of 16 years old, at any location.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-11T10:53:29.11Zmore like thismore than 2024-04-11T10:53:29.11Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1699224
registered interest false remove filter
date less than 2024-03-26more like thismore than 2024-03-26
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Gender Dysphoria: Children and Young People more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government why the National Institute for Health and Care Excellence 2020 evidence review of gender-affirming hormones for children and adolescents with gender dysphoria was not referenced in the list of resources which informed NHS England’s decision on the prescription of gender-affirming hormones for children and adolescents. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL3614 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-09more like thismore than 2024-04-09
answer text <p>NHS England has not adopted a new policy for gender-affirming hormones. NHS England made a consequential amendment to their gender-affirming hormones policy to bring it into alignment with the new puberty suppressing hormones policy. This planned update was set out in the puberty suppressing hormones policy consultation documents.</p><p>NHS England has put additional safeguards on the use of cross-sex hormones, for instance that any prescription to young people aged between 16 and 18 years old must be approved by a national multi-disciplinary team.</p><p>NHS England will continue to review the gender affirming hormone policy in line with the latest clinical advice, and will take note of recommendations set out in the Cass Review, once the final report has been delivered.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-09T13:42:02.44Zmore like thismore than 2024-04-09T13:42:02.44Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1698272
registered interest false remove filter
date less than 2024-03-25more like thismore than 2024-03-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Gender Dysphoria: Children and Young People more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government why NHS England has decided to allow the prescription of gender affirming hormones as a routine commissioning treatment option for young people from around their 16th birthday after only a literature review and without consulting medical and other specialists, or taking note other countries’ experience of such hormones. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL3576 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-09more like thismore than 2024-04-09
answer text <p>NHS England has not adopted a new policy for gender-affirming hormones since 2016. NHS England made a consequential amendment to their gender-affirming hormones policy to bring it into alignment with the new puberty suppressing hormones policy. This planned update was set out in the puberty suppressing hormones policy consultation documents.</p><p>NHS England has put additional safeguards on the use of cross-sex hormones, including that any prescription to young people aged between 16 to 18 must be approved by a national multi-disciplinary team.</p><p>NHS England will continue to review the gender affirming hormone policy in line with the latest clinical advice and take note of recommendations set out once the Cass Review has delivered its final report.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-09T13:09:53.347Zmore like thismore than 2024-04-09T13:09:53.347Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1688792
registered interest false remove filter
date less than 2024-02-12more like thismore than 2024-02-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Health Services: Transgender People more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what discussions they have had with the Royal College of General Practice with regard to its cancellation of a clinical conference organised by the Clinical Advisory Network on Sex and Gender on “Do No Harm” on reducing harm and promoting safe, evidence-based care for gender questioning children and young people. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL2385 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-02-22more like thismore than 2024-02-22
answer text <p>No discussions have been had with the Royal College of General Practitioners about the cancellation of a clinical conference organised by the Clinical Advisory Network on Sex and Gender.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-02-22T12:56:30.27Zmore like thismore than 2024-02-22T12:56:30.27Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1688793
registered interest false remove filter
date less than 2024-02-12more like thismore than 2024-02-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Gender Identity Services for Children and Young People Independent Review more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what discussions they have had with the Royal College of General Practice on the interim report of the Dr Hilary Cass review of Gender Identity Services for Children and Young People submitted to the Department of Health and Social Care in February 2022. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL2386 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-02-21more like thismore than 2024-02-21
answer text <p>No discussions have been had with the Royal College of General Practitioners about the<em> Cass Review of Gender Identity Services for Children and Young People</em>. NHS England commissioned the review and we look forward to the final report, which will be published soon.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-02-21T17:03:23.773Zmore like thismore than 2024-02-21T17:03:23.773Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1664750
registered interest false remove filter
date less than 2023-10-16more like thismore than 2023-10-16
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Brain: Tumours more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to the report by the All-Party Parliamentary Group on Brain Tumours, Pathway to a Cure – breaking down the barriers, published on 28 February 2023, what is the expected timescale to develop a strategy for adequately resourcing discovery, translational and clinical research into brain tumours as recommended by the report; and whether they will commit to ring fencing the recommended £110 million for this resourcing. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL10540 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-24more like thismore than 2023-10-24
answer text <p>The Department of Health and Social Care welcomes the All-Party Parliamentary Group report, recommendations of which continue to be worked through with the Department for Science, Innovation and Technology, UK Research and Innovation and the Medical Research Council (MRC), and with the National Institute for Health and Care Research (NIHR).</p><p>The report recommended action by the research funding agencies on coordinating activities and making funding available. We are taking steps to ensure that funders work closely together to coordinate work along the translational pathway, from the discovery and early translational science typically supported by the MRC, feeding through to the applied health and care research funded by the NIHR.</p><p>It is not usual practice to ring-fence funds for particular topics or conditions. As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area is driven by factors including scientific potential and the number and scale of successful funding applications.</p>
answering member printed Lord Markham more like this
question first answered
less than 2023-10-24T12:16:58.277Zmore like thismore than 2023-10-24T12:16:58.277Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1661509
registered interest false remove filter
date less than 2023-09-18more like thismore than 2023-09-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Health Services: Menopause and Pregnancy more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what discussions they have had with the General Medical Council concerning its removal of the words "mother" and "women" from its internal guidance for pregnant or menopausal staff; and whether this reflects advice to doctors on how to treat and describe patients. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL10236 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-09more like thismore than 2023-10-09
answer text <p>No specific discussions have been had. Ministerial meetings are routinely published on GOV.UK.</p><p>The General Medical Council (GMC) is independent from the Government and its internal guidance is produced for employees of the GMC, not for doctors registered therewith.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2023-10-09T12:03:02.007Zmore like thismore than 2023-10-09T12:03:02.007Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter
1661510
registered interest false remove filter
date less than 2023-09-18more like thismore than 2023-09-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Patients: Women more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether they have reviewed all NHS advice to staff as to the language used to describe female patients. more like this
tabling member printed
Baroness Hayter of Kentish Town more like this
uin HL10237 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-09more like thismore than 2023-10-09
answer text <p>We have been clear that biological sex matters and it is important to use appropriate language that recognises the separate health and biological needs of men and women.</p><p>No review has taken place on all advice to National Health Service staff, but we continue to work with NHS bodies to ensure that women are properly represented in communications and guidance.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2023-10-09T12:02:42.84Zmore like thismore than 2023-10-09T12:02:42.84Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4159
label Biography information for Baroness Hayter of Kentish Town remove filter